@Davisite is it possible to run a small cohort using RC110 under the NPP in France (given Bisantrene is approved there) to test run cardioprotect and FTO before we blow a lot of cash on P1 and P2, to provide proof of concept in the clinic? Assuming RC110 and RC220 would also be considered a new drug from the perspective in France?
Maybe its as simple as RC110 NPP volunteers + hire a trendmill in france : )
Natural cardio protective
Cardioprotective Activity of Randia Dumetorum Against Doxorubicin Induced Cardiotoxicity – Biosciences Biotechnology Research Asia (biotech-asia.org)
General Comments / Chat, page-10405
-
- There are more pages in this discussion • 1,077 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.000(0.00%) |
Mkt cap ! $289.7M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.70 | $1.65 | $100.0K | 59.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 601 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 4823 | 3 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |